| 15370-130 | Carwin Pharmaceutical Associates, LLC DailyMed label | Carwin Pharmaceutical Associates, LLC |
| 15370-130-02 | Carwin Pharmaceutical Associates, LLC DailyMed label | Carwin Pharmaceutical Associates, LLC |
| 15370-130-10 | Carwin Pharmaceutical Associates, LLC DailyMed label | Carwin Pharmaceutical Associates, LLC |
| 23594-101 | These highlights do not include all the information needed to use KARBINAL ® ER safely and effectively. See full prescribing information for KARBINAL ® ER. Karbinal ® ER (carbinoxamine maleate) extended-release oral suspension Initial U.S. Approval: 1953 | Aytu Therapeutics, LLC |
| 23594-101-01 | These highlights do not include all the information needed to use KARBINAL ® ER safely and effectively. See full prescribing information for KARBINAL ® ER. Karbinal ® ER (carbinoxamine maleate) extended-release oral suspension Initial U.S. Approval: 1953 | Aytu Therapeutics, LLC |
| 23594-101-05 | These highlights do not include all the information needed to use KARBINAL ® ER safely and effectively. See full prescribing information for KARBINAL ® ER. Karbinal ® ER (carbinoxamine maleate) extended-release oral suspension Initial U.S. Approval: 1953 | Aytu Therapeutics, LLC |
| 44523-825 | Carbinoxamine Maleate Tablets, USP 4 mg | Biocomp Pharma, Inc. | Mission Pharmacal Company |
| 44523-825-01 | Carbinoxamine Maleate Tablets, USP 4 mg | Biocomp Pharma, Inc. | Mission Pharmacal Company |
| 62542-101 | These highlights do not include all the information needed to use Carbinoxamine Maleate Extended-Release Oral Suspension. See full prescribing information for Carbinoxamine Maleate Extended-Release Oral Suspension. Initial U.S. Approval: 1953 | Neos Therapeutics, LP | Tris Pharma, Inc |
| 62542-101-05 | These highlights do not include all the information needed to use Carbinoxamine Maleate Extended-Release Oral Suspension. See full prescribing information for Carbinoxamine Maleate Extended-Release Oral Suspension. Initial U.S. Approval: 1953 | Neos Therapeutics, LP | Tris Pharma, Inc |
| 64950-211 | Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | Genus Lifesciences Inc. | Mikart |
| 64950-211-01 | Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | Genus Lifesciences Inc. | Mikart |
| 64950-243 | Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | Genus Lifesciences Inc. | Mikart |
| 64950-243-04 | Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | Genus Lifesciences Inc. | Mikart |
| 64950-243-16 | Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | Genus Lifesciences Inc. | Mikart |
| 69067-240 | Carbinoxamine Maleate Tablets, USP 6 mg | Foxland Pharmaceuticals, Inc. |
| 69067-240-20 | Carbinoxamine Maleate Tablets, USP 6 mg | Foxland Pharmaceuticals, Inc. |
| 69315-239 | Leading Pharma, LLC DailyMed label | Leading Pharma, LLC |
| 69315-239-01 | Leading Pharma, LLC DailyMed label | Leading Pharma, LLC |
| 71085-080 | CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | IPG Pharmaceuticals, inc. |
| 71085-080-07 | CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL | IPG Pharmaceuticals, inc. |
| 73684-110 | Carbinoxamine Maleate Tablets, USP 6 mg | BluCrest Pharmaceuticals, LLC |
| 73684-110-60 | Carbinoxamine Maleate Tablets, USP 6 mg | BluCrest Pharmaceuticals, LLC |
| 80705-120 | Carbinoxamine Maleate | TRIPOINT THERAPEUTICS, LLC | Leading Pharma, LLC |
| 80705-120-30 | Carbinoxamine Maleate | TRIPOINT THERAPEUTICS, LLC | Leading Pharma, LLC |